Mammalian Biotech is an advanced research and product engineering organization operating at the intersection of artificial intelligence, biological systems, adaptive cognition, and human–machine interaction.
The organization operates through a distributed network of laboratories, field offices, partner facilities, and temporary research environments. We do not publicly disclose the locations of our operations.
Externally, we present as a small but highly capable research organization focused on the long-term advancement of humans, society, and the environment through applied technological development. Internally, the organization is more difficult to classify. Research areas shift. Teams emerge and disappear. Certain projects appear publicly only through fragments.
The organization maintains a deliberately controlled public profile. Little is fully explained.
Research Areas
Neural Systems. Adaptive Cognition. Biological Interfaces. Human Augmentation. Environmental Integration.
Personnel
Dr. Kenji Watanabe — Founder & Chief Executive Officer
Originally trained in computational neuroscience and systems engineering. Spent early career working across adaptive modeling systems, biological signal processing, and distributed cognitive architectures. Defines institutional direction, shapes research priorities, acts as philosophical anchor, represents Mammalian publicly.
Elena Markovic — Chief Financial Officer
Background combines quantitative finance, operational strategy, and emerging technology investment. Financial strategy, capital allocation, regulatory navigation, institutional scaling.
Dr. Samuel Ivić — Chief Scientific Officer
Leads Mammalian Biotech's scientific research operations. Focuses on biological signal processing, adaptive neural systems, and experimental interface architectures. Oversees scientific programs, defines methodology, reviews technical publications.
Dr. Maya Chen — Senior Researcher, Neural Interface Systems
Works within Mammalian Biotech's neural interface and adaptive cognition programs, focusing on human behavioral adaptation to computational augmentation systems. Human interface studies, behavioral adaptation analysis, cognitive systems evaluation.
Alex Rios — Senior Systems Engineer
Oversees distributed systems integration and infrastructure coordination. Systems engineering, reliability engineering, prototype deployment, failure-mode analysis.
Yuki Tanaka — Laboratory Technologist
Works within Mammalian Biotech's experimental operations environments. Experimental setup, calibration procedures, instrument monitoring, laboratory operations. Very little is publicly known about her beyond operational references and occasional visual documentation.
Naomi Vale — Chief Marketing Officer
Background spans luxury branding, political communications, and unconventional public engagement strategy. Public campaigns, product positioning, narrative framing, media strategy.
Institutional Philosophy
Mammalian Biotech operates on the premise that the most significant technological transitions of the near term are not happening at the frontier of publicly legible research categories. They are happening in the space between categories — between biology and computation, between cognition and infrastructure, between what is possible and what is currently considered appropriate.
We work in that space. We do not expect everyone to find this comfortable. We expect the work to be evaluated on its results.